Iran's new second front at the Red Sea links Gulf rivalry, Somali corridor politics, and…
Hidden factor in cancer treatment timing may affect survival, researchers say
Timing matters: Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical study.
Related Posts
